Document is current

Article History

Received: 29 September 2024

Accepted: 18 April 2025

First Online: 21 December 2025

Declarations

:

: Maria Paola Martelli declares honoraria/consultancy at scientific advisory boards for AbbVie, Amgen, BMS, Delbert, Janssen, Novartis, Pfizer, and Jazz Pharmaceuticals. Maria Teresa Voso declares: research support from Celgene/BMS and Novartis; speakers'bureau participation for Celgene/BMS, Astellas, Jazz, AbbVie, Novartis, and AstraZeneca; advisory board membership for Celgene/BMS, Jazz, and Syros. Alencar Alvaro declares research funding from Incyte, BeiGene, and LOXO/Lilly; honoraria from Dr. Reddy; and advisory board membership for ADC Therapeutics, BeiGene, AbbVie, Lilly, Genentech, Amgen, Incyte, and Janssen. Naveen Pemmaraju declares: Board of Directors/Management: Dan's House of Hope. Consulting/Scientific Advisory Board/Speaking: AbbVie, Aplastic Anemia & MDS International Foundation, Aptitude Health, Astellas Pharma US, Blueprint Medicines, Bristol-Myers Squibb Pharmaceuticals, CancerNet, CareDx, Celgene, Cimeio Therapeutics AG, ClearView Healthcare Partners, CTI BioPharma, Curio Science, Dava Oncology, EUSA Pharma, Harborside Press, Imedex, Immunogen, Intellisphere, Karyopharm, Magdalen Medical Publishing, Medscape, Menarini Group, Morphosys, Neopharm, Novartis Pharmaceuticals, OncLive, Pacylex, Patient Power, PeerView Institute for Medical Education, Pharma Essentia, Physician Education Resource (PER). Leadership: ASH Committee on Communications, ASCO Cancer.Net Editorial Board. Licenses: Karger Publishers. Research (Grant): United States Department of Defense (DOD), National Institute of Health/National Cancer Institute (NIH/NCI). Uncompensated: HemOnc Times/Oncology Times. Marina Konopleva declares research funding and consulting fees from AbbVie, Allogene, AstraZeneca, Auxenion, Bakx, Boehringer, Dark Blue Therapeutics, F. Hoffman-La Roche, Genentech, Gilead, ImmunoGen, Janssen, Legend, MEI Pharma, Precision, Rafael, Redona, Sanofi, Sellas, Stemline, and Vincerx. All other authors declare no conflicts of interest. Author Consolato M. Sergi MD has a position on the editorial board of Discover Oncology, and was not involved in the review or decisions related to this article.